MEDIROM Healthcare Technologies PE Ratio 2021-2023 | MRM
Current and historical p/e ratio for MEDIROM Healthcare Technologies (MRM) from 2021 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MEDIROM Healthcare Technologies PE ratio as of September 19, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| MEDIROM Healthcare Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-09-20 | 3.90 | inf | |
| 2021-06-30 | 9.70 | 0 | 0.00 |
| 2023-12-31 | 5.72 | 0 | 0.00 |
| 2023-06-30 | 5.43 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.019B | $0.049B |
| MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.223B | 12.84 |
| Quest Diagnostics (DGX) | United States | $17.268B | 17.71 |
| DaVita (DVA) | United States | $13.687B | 16.84 |
| Encompass Health (EHC) | United States | $9.264B | 22.79 |
| Chemed (CHE) | United States | $8.808B | 27.08 |
| Elanco Animal Health (ELAN) | United States | $7.449B | 16.74 |
| Option Care Health (OPCH) | United States | $5.396B | 26.51 |
| RadNet (RDNT) | United States | $5.150B | 122.18 |
| Amedisys (AMED) | United States | $3.183B | 22.77 |
| Astrana Health (ASTH) | United States | $2.839B | 40.17 |
| LifeStance Health (LFST) | United States | $2.625B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.408B | 29.24 |
| U.S Physical Therapy (USPH) | United States | $1.282B | 34.70 |
| Pennant (PNTG) | United States | $1.076B | 51.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.063B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.211B | 0.00 |
| Daxor (DXR) | United States | $0.044B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.025B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |